Skip to main content

Part of the book series: Current Clinical Pathology ((CCPATH))

  • 302 Accesses

Abstract

Obstetricians and reproductive immunologists have long recognized that the mother’s immune response is significantly affected by pregnancy. Immunologic diseases of pregnancy are known to impact maternal, fetal, and neonatal well-being. Effective management of human pregnancy requires an understanding of both the normal maternal adaptations to pregnancy and immune-related disorders associated with gestation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 114 - 118.

    Article  PubMed  CAS  Google Scholar 

  2. Krause PJ, Ingardia CJ, Pontius LT, Malech HL, LoBello TM, Maderazo EG. Host defense during pregnancy: Neutrophil chemotaxis and adherence. Am J Obstet Gynecol 1987; 157: 274 - 280.

    PubMed  CAS  Google Scholar 

  3. Salmeron O, Vaquer S, Salmeron I, et al. Pregnancy is associated with a reduction in the pattern of the cytotoxic activity displayed by lymphokine-activated killer cells. Am J Reprod Immunol 1991; 26: 150 - 155.

    PubMed  CAS  Google Scholar 

  4. Hidaka Y, Amino N, Iwatani Y, et al. Changes in natural killer cell activity in normal pregnant and postpartum women: increases in the first trimester and postpartum period and decreases in late pregnancy. J Reprod Immunol 1991; 20: 73 - 83.

    Article  PubMed  CAS  Google Scholar 

  5. Castilla J, Rueda R, Vargas, M, Gonzalez-Gomez F, Garcia-Olivares E. Decreased levels of circulating CD4+ T lymphocytes during normal human pregnancy. J Reprod Immunol 1989; 7: 103 - 111.

    Article  Google Scholar 

  6. Nakamura N, Miyazaki K, Kitano Y, Fujisaki S, Okamura H. Suppression of cytotoxic lymphocyte activity during pregnancy. J Reprod Immunol 1993; 23: 119 - 130.

    Article  PubMed  CAS  Google Scholar 

  7. Sargent IL. Maternal and fetal immune responses during preganancy. Exp Clin Immunogenet 1993; 10: 85 - 102.

    PubMed  CAS  Google Scholar 

  8. Feinberg BB, Gonik B. General precepts of the immunology of pregnancy. Clin Obstet Gynecol 1991; 34: 3 - 16.

    Article  PubMed  CAS  Google Scholar 

  9. Weinberg ED. Pregnancy: associated depression of cell-mediated immunity. Rev Infect Dis 1984; 6: 814 - 831.

    Article  PubMed  CAS  Google Scholar 

  10. Brabin BJ. Epidemiology of infection in pregnancy. Rev Infect Dis 1985; 7: 579 - 603.

    Article  PubMed  CAS  Google Scholar 

  11. Drutz DJ, Cantanzara A. Coccidiodomycosis. Am Rev Resp Dis 1978: 117: 727 - 771.

    PubMed  CAS  Google Scholar 

  12. Stagno S, Reynolds DW, Huang ES, Thames SD, Smith RJ, Alford CA. Congenital cytomegalovirus infection: occurrence in an immune population. N Engl J Med. 1977; 296: 1254 - 1258.

    Article  PubMed  CAS  Google Scholar 

  13. Siegel M, Greenberg M. Incidence of poliolyelitis in pregnancy. N Engl J Med. 1955; 253: 841 - 847.

    Article  PubMed  CAS  Google Scholar 

  14. Weinstein I, Aycock WL, Feemster RF. The relation of sex, pregnancy and menstruation to susceptibility to poliomyelitis. N Engl J Med 1951; 245: 54 - 58.

    Article  PubMed  CAS  Google Scholar 

  15. Priddle HD, Lenz WR, Young DL, Stevenson CS. Poliomyelitis in pregnancy and the puerperium. Am J Obstet Gynecol 1952: 63: 408 - 413.

    PubMed  CAS  Google Scholar 

  16. DCruz IA, Balani SG, Iyer LS. Infectious hepatitis and pregnancy. Obstet Gynecol 1968; 31: 449 - 455.

    CAS  Google Scholar 

  17. Borhanmanesh F, Haghighi P, Hekman K, et al. Viral hepatitis during pregnancy. Gasteroenterology, 1973; 64: 304 - 312.

    CAS  Google Scholar 

  18. Morrow RH, Smetana HF, Sai FT, Edgecomb JK. Unusual features of viral hepatitis in Accra, Ghana. Ann Intern Med 1968; 68: 1250 - 1264.

    PubMed  Google Scholar 

  19. Greenberg M, Jocobziner H, Parker J, et al. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol 1958; 76: 897 - 902.

    PubMed  CAS  Google Scholar 

  20. Freeman DW, Barno A. Deaths from Asian influenza associated with pregnancy. Am J Obstet Gynecol 1959; 78: 1172 - 1175.

    PubMed  CAS  Google Scholar 

  21. Diro M, Beydoun SN. Malaria in pregnancy. South Med J 1982; 75: 959 - 962.

    Article  PubMed  CAS  Google Scholar 

  22. Hedvall E. Pregnancy and tuberculosis. Acta Med Scand 1953; 147 (suppl 286): 3 - 101.

    Google Scholar 

  23. Murray DL, Imagawa DT, Okada DM, St. Genre JW. Antibody response to monovalent A/New Jersey/ 8/76 influenza vaccine in pregnant women. J Clin Microbiol 1979; 10: 184 - 187.

    PubMed  CAS  Google Scholar 

  24. Lichtenstein MR. Tuberculin reaction in tuberculosis during pregnancy. Am Rev Tuber 1942: 46: 89 - 92.

    Google Scholar 

  25. Shahid NS, Steinhoff MC, Roy E, Begum T, Thompson CM, Siber GR. Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation. Vaccine 2002; 20: 2404 - 2409.

    Article  PubMed  CAS  Google Scholar 

  26. Maral I, Cerak M, Aksakal FN, Baykan Z, Kayikcioglu F, Bumin MA. Tetanus immunization in pregnant women: serum levels of antitetanus antibodies at the time of delivery. Eur J Epidemiol 2001; 17: 661 - 665.

    Article  PubMed  CAS  Google Scholar 

  27. Munoz FM, Englund JA. Vaccines in pregnancy. Infect Dis Clin North Am 2001; 150: 253 - 271.

    Article  Google Scholar 

  28. Medawar PB. Some immunological and endocrinological problems raised by evolution of viviparity in vertebrates. Symp Soc Exp Biol 1953; 320 - 323.

    Google Scholar 

  29. Munz C, Holmes N, King A, et al. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997; 185: 385 - 391.

    Article  PubMed  CAS  Google Scholar 

  30. Mosmann TR, Cherwinshi H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348 - 2357.

    PubMed  CAS  Google Scholar 

  31. Mosmann TR, Coffman RL. Th 1 and Th2 cells: different patterns of lymphokine secretion according to profiles of lymphokine activities and secreted proteins. J Immunol 1989; 136: 2348 - 2357.

    Google Scholar 

  32. Wegmann TG, Lin H, Guilbert L, Mossman TH. Bidirectional cytokine interactions in the materno-fetal relationship: successful allopregnancy is a Th2 phenomenon. Immunol Today 1993; 14: 353 - 355.

    Article  PubMed  CAS  Google Scholar 

  33. Varner MW. Autoimmune disorders and pregnancy. Semin Perinatol 1991; 15: 238 - 250.

    PubMed  CAS  Google Scholar 

  34. Piccini MP, Giudizi MG, Biagiotti R, et al. Progesterone favors the development of human T-helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Thl cell clones. J Immunol 1995; 155: 128 - 133.

    Google Scholar 

  35. Kelly RW, Critchley HO. A T-helper-2 bias in decidua: the prostaglandin contribution of the macrophage and trophoblast. J Reprod Immunol 1997; 33: 181 - 187.

    Article  PubMed  CAS  Google Scholar 

  36. Kuhn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263 - 274.

    Article  PubMed  CAS  Google Scholar 

  37. Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998; 179: 80 - 86.

    Article  PubMed  CAS  Google Scholar 

  38. Koumandakis E, Koumandaki L, Kaklamani E, Sparos L, Aravantinos D, Trichopoulos D. Br J Obstet Gynecol 1986; 93: 1150 - 1154.

    Article  CAS  Google Scholar 

  39. Shibuya T, Izuchi K, Kuroiwa A, Okabe N, Shirakawa K. Study on nonspecific immunity in pregnant women: increased chemi-luminescence response of peripheral blood phagocytes. Am J Reprod Immunol Microbiol 1987; 15: 19 - 23.

    PubMed  CAS  Google Scholar 

  40. Shillingford AJ, Weinger S. Maternal issues affecting the fetus. Clin Perinatol. 2001; 28: 31 - 70.

    Article  PubMed  CAS  Google Scholar 

  41. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989; 160: 63 - 70.

    PubMed  CAS  Google Scholar 

  42. Burrow GN. The management of thyrotoxicosis in pregnancy. N Eng J Med 1985; 313: 562 - 565.

    Article  CAS  Google Scholar 

  43. Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am 1998; 27: 127 - 149.

    Article  PubMed  CAS  Google Scholar 

  44. Mulder JE. Thyroid disease in women. Med Clin North Am 1998; 82: 103 - 125.

    Article  PubMed  CAS  Google Scholar 

  45. Polak M. Hyperthyroidism in early infancy: pathophysiology, clinical features, and diagnosis with a focus on neonatal hyperthyroidism. Thyroid 1998; 8: 1171 - 1177.

    Article  PubMed  CAS  Google Scholar 

  46. Krude H, Bierbermann H, Krohn HP, Dralle H, Gruthers A. Congenital hyperthyroidism. Exp Clin Endocrinol Diabetes 1997; 105: 6 - 11.

    Article  PubMed  CAS  Google Scholar 

  47. Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am 1998; 27: 127 - 149.

    Article  PubMed  CAS  Google Scholar 

  48. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999; 9: 727 - 733.

    Article  PubMed  CAS  Google Scholar 

  49. Messer PM, Hauffa BP, Olbright T, et al. Antithyroid drug treatment of Graves disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function in offspring. Acta Endocrinol (Copenh) 1990; 123: 311 - 316.

    CAS  Google Scholar 

  50. McKenzie JM, Zakarija M. Clinical review 3: the clinical use of thyrotropin receptor antibody measurements. J Clin Endocrinol Metab 1989; 69: 1093 - 1096.

    Article  PubMed  CAS  Google Scholar 

  51. Mestman JH, Goodwin M, Montoro MM. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am 1995; 24: 41 - 71.

    PubMed  CAS  Google Scholar 

  52. Wenstrom KD, Weiner CP, Williamson RA, Grant SS. Perinatal diagnosis of fetal hyperthyroidism using funipuncture. Obstet Gynecol 1990; 76: 513 - 517.

    PubMed  CAS  Google Scholar 

  53. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV. Systemic lupus erythematosus. Lancet 2001; 357: 1027 - 1032.

    Article  PubMed  CAS  Google Scholar 

  54. Sontheimer RD, Gilliam JN. Systemic lupus erythematosus and the skin. In Lahita RG ed. Systemic Lupus Erythematosus and the Skin, 2nd ed. New York: Churchill Livingstone, 1992, p. 657.

    Google Scholar 

  55. Carmona F, Font J, Cervera R, Munoz F, Cararach V, Balasch J. Obstetrical outcomes of pregnancy in patients with systemic lupus erythematosus: a study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999; 83: 137 - 142.

    Article  PubMed  CAS  Google Scholar 

  56. Brustein D, Rodriguez JM, Minkin W, Rabhan NB. Familial lupus erythematosus. 1977; 238: 2294 - 2296.

    CAS  Google Scholar 

  57. Bunyon JP, Hebert R, Copel J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national lupus registry. J Am Coll Cardiol 1998; 31: 1658 - 1666.

    Article  Google Scholar 

  58. Bunyon JP, Waltuck J, Klein C, Kleinman C, Capel J. In utero identification and therapy of CHB. Lupus 1995; 4: 116 - 121.

    Article  Google Scholar 

  59. Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993; 82: 11 - 16.

    PubMed  CAS  Google Scholar 

  60. Horsfall AC, Venables PJW, Taylor PV, Maini RN. Ro and La antigens and maternal anti-La idiotype on the surface of myocardial mibres in congenital heart block. J Autoimmun 1991; 4: 165 - 176.

    Article  PubMed  CAS  Google Scholar 

  61. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective tissue disease, autoantibodies to ribonucleoprotein and cogenital heart block. N Engl J Med 1983; 309: 209 - 212.

    Article  PubMed  CAS  Google Scholar 

  62. Boutjdir M, Zhang Z, Chen L, et al. Electrophysiologic characterization of purified IgG from a mother whose child has congenital heart block (CHB) on L-type calcium currents (Ica). Arthritis Rheum 1995; 38: S230.

    Google Scholar 

  63. Copel JA, Bunyon JP, Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995; 173: 1384 - 1390.

    Article  PubMed  CAS  Google Scholar 

  64. Bhandari S, Harnden P, Brownjohn AM, Turney JH. Association of anticardiolipin antibodies with intraglomerular thrombi and renal dysfunction in lupus nephtitis. QJM 1998; 91: 401 - 409.

    Article  PubMed  CAS  Google Scholar 

  65. Swadzba J, DeClerck LS, Stevens WJ, et al. Anticardiolipin, anti-beta (2) glycoprotein I antiprothrombin antibodies and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheum 1997; 24: 1710 - 1715.

    PubMed  CAS  Google Scholar 

  66. Provost TT, Watson R. Anti-Ro (SSA) HLA-DR3-positive women: the interrelationship between serum ANA negative, SS, SCLE, and NLE mothers and S/LE overlap female patients. J Invest Dermatol 1993; 100: 14S - 20S.

    Article  PubMed  CAS  Google Scholar 

  67. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med: 2002; 346: 752 - 763.

    Article  PubMed  CAS  Google Scholar 

  68. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheum 1992; 19: 508 - 512.

    PubMed  CAS  Google Scholar 

  69. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop, 4 April 1986. Clin Exp Immunol 1987; 68: 215 - 222.

    PubMed  CAS  Google Scholar 

  70. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Antiphospholipid antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1 - 6.

    Article  PubMed  CAS  Google Scholar 

  71. Branch DW, Scott JR, Kochenour NK, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322 - 1326.

    Article  PubMed  CAS  Google Scholar 

  72. Cowchock S, Smith JB, Gocial B. Antibodies to phospholipids and nuclear antigens in patients with repeated abortions. Am J Obstet Gynecol 1986; 155: 1002 - 1010.

    PubMed  CAS  Google Scholar 

  73. Unander AM, Norberg R, Hahn L, Arfors L. Anticardiolipin antibodies and complement in 99 women with habitual abortions. Am J Obstet Gynecol 1987; 156: 114 - 119.

    PubMed  CAS  Google Scholar 

  74. Barbui T, Cortelazzo S, Galli M, et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril 1988; 50: 589 - 592.

    PubMed  CAS  Google Scholar 

  75. Deleze M, Alarcon-Segovia D, Valdes-Macho E, Oria CV, Ponce de Leon S. Relationship between antiphospholipid antibodies and recurrent fetal loss in patients with systemic lupus erythematosus and apparently healthy women. J Rheumatol 1989; 16: 768 - 772.

    PubMed  CAS  Google Scholar 

  76. Parke A, Maier D. Habitual fetal loss may indicate autoimmune disease. Fertil Steril 1989; 51: 280 - 285.

    PubMed  Google Scholar 

  77. Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990; 163: 210 - 216.

    PubMed  CAS  Google Scholar 

  78. Beaumont JL. Syndrome hemorrhagique acuquis du a un anticoagulant circulant. Sangre 1964; 25: 1 - 15.

    Google Scholar 

  79. Vinter D, Dufour P, Cosson M, Houpeau JL. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 2001; 96: 37 - 50.

    Article  Google Scholar 

  80. Branch DW, Scott JR. Clinical implications of antiphospholipid antibodies: the Utah experience. In Harris EN, Exner T, Hughes GRV, Asherson RA, eds, Phospholipid Binding Antibodies. Boca Raton, FL: CRC Press, 1991, pp. 335 - 346.

    Google Scholar 

  81. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 1992; 80: 614 - 620.

    PubMed  CAS  Google Scholar 

  82. Rai RS, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995; 10: 3301 - 3304.

    PubMed  CAS  Google Scholar 

  83. Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369 - 373.

    PubMed  CAS  Google Scholar 

  84. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993; 100: 909 - 913.

    Article  PubMed  CAS  Google Scholar 

  85. Lynch A, Marlar R, Murphy J, et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. Ann Intern Med 1994; 120: 470 - 475.

    PubMed  CAS  Google Scholar 

  86. Yasuda M, Takakuwa K, Tokunga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995; 86: 555 - 559.

    PubMed  CAS  Google Scholar 

  87. Out HJ, Bruinse HW, Christianens GC, et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992; 167: 26 - 32.

    PubMed  CAS  Google Scholar 

  88. Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and beta2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod 1995; 10: 2001 - 2005.

    PubMed  CAS  Google Scholar 

  89. Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87: 489 - 493.

    Article  PubMed  CAS  Google Scholar 

  90. Petri M, Hopkins. Lupus pregnancy center: 1987 to 1996. Rheum Dis Clin North Am 1997; 23: 1 - 13.

    Article  PubMed  CAS  Google Scholar 

  91. Out HJ, Bruinse HW, Derksen RH. Antiphospholipid antibodies and pregnancy loss. Hum Reprod 1991; 6: 889 - 897.

    PubMed  CAS  Google Scholar 

  92. Parazzini F, Acaia B, Faden D, Lovotti M, Marelli G, Cortelazzo S. Antiphospholipid antibodies and recurrent abortion. Obstet Gynecol 1991; 77: 854 - 858.

    PubMed  CAS  Google Scholar 

  93. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991; 34: 1231 - 1235.

    Article  PubMed  CAS  Google Scholar 

  94. MacLean MA, Cumming GP, McCall F, Walker ID, Walker JJ. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages. Br J Obstet Gynecol 1994; 101: 103 - 106.

    Article  CAS  Google Scholar 

  95. Balasch J, Creus M, Fabregues F, et al. Antiphospholipid antibodies and human reproductive failure. Hum Reprod 1996; 11: 2310 - 2315.

    Article  PubMed  CAS  Google Scholar 

  96. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR. Thrombosis, recurrent fetal loss and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153 - 2156.

    Article  PubMed  CAS  Google Scholar 

  97. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486 - 489.

    PubMed  CAS  Google Scholar 

  98. Brey RL, Gharavi AE, Lockshin MD. Neurological complications of antiphospholipid antibodies. Rheum Dis Clin North Am 1993; 19: 833 - 850.

    PubMed  CAS  Google Scholar 

  99. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303 - 308.

    PubMed  CAS  Google Scholar 

  100. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993 - 997.

    Article  PubMed  CAS  Google Scholar 

  101. Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology 1990; 40: 1190 - 1196.

    Article  PubMed  CAS  Google Scholar 

  102. Ferro D, Quintarelli C, Rasura M, Antionini G, Violi F. Lupus anticoagulant and the fibrinolytic system in young patients with stroke. Stroke 1993; 24: 368 - 370.

    Article  PubMed  CAS  Google Scholar 

  103. Chapman J, Shoenfeld Y. Neurological and neuroendocrine-cytokine inter-relationship in the antiphospholipid syndrome. Ann NY Acad Sci 2002; 966: 415 - 424.

    Article  PubMed  CAS  Google Scholar 

  104. Lima F, Khamashta MA, Buchanan NMM, Kerslake S, Hunt BJ, Hughes GR. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996; 14: 131 - 136.

    PubMed  CAS  Google Scholar 

  105. Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Hematol 1985; 59: 227 - 250.

    Article  CAS  Google Scholar 

  106. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The primary antiphospholipid syndrome: major clincial and serological features. Medicine 1989; 68: 366 - 374.

    Article  PubMed  CAS  Google Scholar 

  107. Branch DW, Andres R, Digre KB, Rote NS, Scott JR. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989; 73: 541 - 545.

    PubMed  CAS  Google Scholar 

  108. Milliez J, Delong F, Bayani N, et al. The prevalence of autoantibodies during third trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol 1991; 165: 51 - 56.

    PubMed  CAS  Google Scholar 

  109. Sletnes KE, Wislof F, Moe N, Dale PO. Antiphospholipid antibodies in preeclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992; 71: 112 - 117.

    Article  PubMed  CAS  Google Scholar 

  110. Moodley J, Bhoola V, Cuursma J, Pudfin D, Byrne S, Kenoyer DG. The association of antiphospholipid antibodies with severe early onset preeclampsia. S Afr Med J 1995; 85: 105 - 107.

    PubMed  CAS  Google Scholar 

  111. Rivier G, Herranz MT, Khamashta MA, Hughes GR. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus 1994; 3: 85 - 90.

    Article  PubMed  CAS  Google Scholar 

  112. Rai R, Cohen H, Dave M, Regan I. Randomized controlled trial of aspirin and asprin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997; 314: 253 - 257.

    Article  CAS  Google Scholar 

  113. Coulam CB, McIntyre JA, Wagenknecht D, Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies. Lancet 1990; 335: 865.

    Article  PubMed  CAS  Google Scholar 

  114. Peaceman AM, Silver RK, MacGregor SN, Socol ML. Interlaboratory variation in antiphospholipid antibody testing. Am J Obstet Gynecol 1992; 166: 1784 - 1787.

    Google Scholar 

  115. Harris EN, Spinnato JA. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991; 165: 1272 - 1277.

    PubMed  CAS  Google Scholar 

  116. Vaarala O, Palusuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41: 8 - 15.

    Article  PubMed  CAS  Google Scholar 

  117. Silver RM, Porter TF, van Leeuwen I, Jeng G, Scott JR, Branch DW. Anticardiolipin antibodies: clincial consequences of low titers. Obstet Gynecol 1996; 87: 494 - 500.

    Article  PubMed  CAS  Google Scholar 

  118. Alarcon-Segovia D, Perez-Vasquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome with systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 275 - 286.

    Article  PubMed  CAS  Google Scholar 

  119. Branch DW, Silver RM, Pierangeli SS, van Leeuwen I, Harris EN. Antiphospholipid antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol 1997; 89: 549 - 555.

    Article  PubMed  CAS  Google Scholar 

  120. Silver R, Branch W, Scott J. Maternal thrombocytopenia in pregnancy: time for reassessment. Am J Obstet Gynecol 1995; 173; 479 - 482.

    Article  PubMed  CAS  Google Scholar 

  121. Burrow R, Kelton J, Thrombocytopenia in delivery: a prospective study of 6715 deliveries. Am J Obstet Gynecol 1990; 162: 731 - 734.

    Google Scholar 

  122. Biswas A, Arulkumaran S, Ratnam S. Disorders of platelets in pregnancy. Obstet Gynecol Sury 1994; 49: 585 - 594.

    Article  CAS  Google Scholar 

  123. Al-Mofada S, Osman M, Kides E, al Momen AK, al Herbish AS, al Mobaireck K. Risk of thrombocytopenia in the infants of mothers with idiopathic thrombocytopenia. Am J Perinatol 1994; 6: 423 - 426.

    Article  Google Scholar 

  124. Paides M, Haut M, Lockwood C. Platelet disorders in pregnancy: implications for mother and fetus. Mt Sinai J Med 1994; 61: 389 - 403.

    Google Scholar 

  125. Mennell J, Bussel J. Antenatal management of the thrombocytopenias. Clin Perinatol 1994; 21: 591 - 614.

    Google Scholar 

  126. Jaff M. Medical aspects of pregnancy. Cleveland Clin J Med 1994; 61: 263 - 271.

    CAS  Google Scholar 

  127. Rose V, Gordon I. Idiopathic thrombocytopenia purpura in pregnancy: successful management with immunoglobulin infusion. JAMA 1985; 254: 2626 - 2628.

    Article  PubMed  CAS  Google Scholar 

  128. Howe SE, Lynch DM, Lynch JM. An enzyme-linked immunosorbent assay for the quantification of serum platelet-bindable IgG. Transfusion 1984; 24: 348 - 352.

    Article  PubMed  CAS  Google Scholar 

  129. Hedge UM, Ball S, Zuiable A, Roter BL. Platelet-associated immunoglobulins (PAIgG and PaigM) in autoimmune thrombocytopenia. Br J Haematol 1985; 59: 221 - 226.

    Article  Google Scholar 

  130. Lynch DM, Lynch JM, Howe SE. A quantitative ELISA procedure for the measurement of membrane-bound platelet-associated IgG (PAIgG). Am 7 Clin Pathol 1985; 83: 331 - 336.

    CAS  Google Scholar 

  131. Hegde UM. Platelet antibodies in immune thrombocytopenia. Blood Rev 1992; 6: 34 - 42.

    Article  PubMed  CAS  Google Scholar 

  132. Joutsi-Korhonen L, Javela K, Hormila P, Kekomaki R. Glycoprotein V-specific platelet-associated antibodies in thrombocytopenic patients. Clin Lab Hematol 2001; 23: 307 - 312.

    Article  CAS  Google Scholar 

  133. Garner SF, Campbell K, Metcalfe P, et al. Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia. Blood 2002; 100: 344 - 346.

    Article  PubMed  CAS  Google Scholar 

  134. Bussel JB. Immune thrombocytopenia in pregnancy: autoimmune and alloimmune. J Reprod Immunol 1997; 37: 35 - 61.

    Article  PubMed  CAS  Google Scholar 

  135. Plauche W. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991; 34: 82 - 99.

    Article  PubMed  CAS  Google Scholar 

  136. Rowland L. Controversies about the treatment of myasthenia gravis. J Neurol Neurosurg Psych 1980; 43: 644 - 659.

    Article  CAS  Google Scholar 

  137. Vernet-der Garbedian B, Lacokova M, Eymard B, et al. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J Clin Invest 1994; 94: 555 - 559.

    Article  Google Scholar 

  138. Matthews I, Sims G, Ledwidge S, et al. Antibodies to acetylcholine receptor in parous women with myasthemia: evidence for immunization by fetal antigen. Lab Invest 2002; 82: 1407 - 1417.

    PubMed  CAS  Google Scholar 

  139. Plauche WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991; 34: 82 - 99.

    Article  PubMed  CAS  Google Scholar 

  140. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psych 1985; 48: 1246 - 1252.

    Article  CAS  Google Scholar 

  141. Hinman CL, Ernstoff RM, Montgomery IN, Hudson RA, Rauch HC. Clinical correlates of enzyme-immunoassay versus radioimmunoassay measurements of antibody acetylcholine receptor in patients with myasthenia gravis. J Neurol Sci 1986; 75: 305 - 316.

    Article  PubMed  CAS  Google Scholar 

  142. Howard FM Jr. Lennon VA, Finley J, Matsumato J, Elveback LR. Clinical correlations of antibodies that bind, block or modulate human acetylcholine receptors in myasthenia gravis. Ann. NY Acad Sci 1987; 505: 526 - 538.

    Article  PubMed  Google Scholar 

  143. Jailkhani BL, Asthana D, Jafferey NF, Khajuria A, Subbalaxmi B, Ahuja GK. ELISA for detection of IgG and IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis. Ind J Med Res 1986; 83: 187 - 195.

    CAS  Google Scholar 

  144. Vernet-der Garabedian B, Lacokova M, Eymard B, et al. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J Clin Invest 1994; 94: 555 - 559.

    Article  Google Scholar 

  145. Gardnerova M, Eymard B, Morel E, et al. The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn. Neurology 1997; 48: 50 - 54.

    Article  PubMed  CAS  Google Scholar 

  146. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrositis and intermittent hydraarthrosis. Proc Staff Meet Mayo Clin 1938; 3: 161 - 167.

    Google Scholar 

  147. Oka M, Vainio U. Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheum Scand 1966; 12: 47 - 52.

    PubMed  CAS  Google Scholar 

  148. Neely NT, Persellin RH. Activity of rheumatoid arthritis during pregnancy. Texas Med 1977; 73: 59 - 63.

    CAS  Google Scholar 

  149. Persellin RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1977; 27: 992 - 997.

    Google Scholar 

  150. Ostensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arch Rheum 1983; 26: 1155 - 1159.

    Article  CAS  Google Scholar 

  151. Ostensen M, Husby G. Pregnancy and rheumatic disease: a review of recent studies in rheumatoid arthritis and ankylosing spondylitis. Klin Wochenschr 1984; 62: 891 - 895.

    Article  PubMed  CAS  Google Scholar 

  152. Bulmash JM. Rheumatoid arthritis and pregnancy. Obstet Gynecol 1985; 8: 223 - 276.

    Google Scholar 

  153. Ostensen M, Aune LB, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983; 12: 69 - 72.

    Article  PubMed  CAS  Google Scholar 

  154. Takeuchi A, Persellin RH. The inhibitory effect of pregnancy serum on polymorphonuclear leukocyte chemotaxis. J Clin Lab Immunol 1980; 3: 121 - 124.

    PubMed  CAS  Google Scholar 

  155. Lahita RG. Sex steroids and the rheumatic diseases. Arthritis Rheum 1985; 28: 121 - 126.

    Article  PubMed  CAS  Google Scholar 

  156. Talal N, Ahmed SA. Immunomodulation by hormones: an area of growing importance. J Rheumatol 1987; 14: 191 - 193.

    PubMed  CAS  Google Scholar 

  157. Muller B, Gimsa U, Mitchison NA, Radbruch A, Sieper J, Yin S. Modulating the Thl/Th2 balance in inflammatory arthritis. Sem Immunopathol 1998; 20: 181 - 196.

    Article  CAS  Google Scholar 

  158. Lane P. Common variable immunodeficiency: does life begin at 40? Clin Exp Immunol 1994; 95: 201 - 203.

    Article  PubMed  CAS  Google Scholar 

  159. Hammarstrom L, Gilner M, Smith C. Molecular basis for human immunodeficiencies. Curr Opin Immunol 1993; 5: 579 - 584.

    Article  PubMed  CAS  Google Scholar 

  160. Holland N, Holland P. Immunological maturation in an infant of an agammaglobulinemic mother. Lancet 1966; 2: 1152 - 1155.

    Article  PubMed  CAS  Google Scholar 

  161. Laursen H, Christensen M. Immunoglobulins in normal infant born of severe hypogammaglobulinemic mother. Arch Dis Child 1973; 48: 646 - 648.

    Article  PubMed  CAS  Google Scholar 

  162. Kobayashi R, Hyman C, Stiehm E. Immunologic maturation in an infant born to a mother with agammaglobulinemia. Am J Dis Child 1980; 1334: 942 - 944.

    Google Scholar 

  163. Dams E, Van der Meer J. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies. Lancet 1995; 345: 864.

    Article  PubMed  CAS  Google Scholar 

  164. Hauser C, Buriot D. Gamma globulin therapy during pregnancy in mothers with hypogammaglobulinemia. Am J Obstet Gynecol 1982; 144: 112.

    Google Scholar 

  165. Madsen D, Catanzarite V, Varela Gittling F. Common variable hypogammaglobulinemia in pregnancy: treatment with high dose immunoglobulin infusions. Am J Hematol 1986; 21: 327 - 329.

    Article  PubMed  CAS  Google Scholar 

  166. Slade H. Human immunoglobulins for intravenous use and hepatitis C viral transmission. Clin Diag Lab Immunol 1994; 6: 613 - 619.

    Google Scholar 

  167. Report of a WHO Scientific Group. Primary immunodeficiency disease. Immunodef Rev 1992; 3: 195.

    Google Scholar 

  168. Ammann A, Hong R. Selective IgA deficiency: presentation of 30 cases and a review of the literature. Medicine 1971; 50: 223 - 236.

    Article  PubMed  CAS  Google Scholar 

  169. Bluestone R, Goldberg L, Katz R, Marchesano JM, Calabro JJ. Juvenile rheumatoid arthritis: a serologic survey of 200 consecutive patients. J Pediatr 1970; 77: 98 - 102.

    Article  PubMed  CAS  Google Scholar 

  170. Finley S, Finley W, Noto R, et al. IgA absence associated with a ring-18 chromosome. Lancet 1968; 1: 1095 - 1096.

    Article  PubMed  CAS  Google Scholar 

  171. Stewart JM, Go S, Ellis E, Robinson A. Absent IgA and deletions of chromosome 18. J Med Genet 1970; 7: 11 - 19.

    Article  PubMed  CAS  Google Scholar 

  172. Volankis JE, Zhu ZB, Schaffer FM, et al. Major histocompatibility complex III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency. J Clin Invest 1992; 89: 1914 - 1922.

    Article  Google Scholar 

  173. Douglas SD, Goldberg LS, Gudenberg HH, et al. Agammaglobulinemia and co-existent pernicious anemia. Clin Exp Immunol 1970; 6: 181 - 187.

    PubMed  CAS  Google Scholar 

  174. Kirkpatrick C. Chronic mucocutaneous candidiasis. J Am Acad Dermatol 1994; 31: S14 - S17.

    Article  PubMed  CAS  Google Scholar 

  175. Oyefara B, Kim H, Danziger RN, Carroll M, Greene JM, Douglas SD. Autoimmune hemolytic anemia in chronic mucocutaneous candidiasis. Clin Diagn Lab Immunol 1994; 1: 38 - 43.

    PubMed  CAS  Google Scholar 

  176. Bentur L, Nisbet-Brown E, Levison H, Roifman CM. Lung disease associated with IgG subclass deficiency in chronic mucocutaneous candidiasis. J Pediatr 1991; 118: 82 - 86.

    Article  PubMed  CAS  Google Scholar 

  177. Aaltonen J, Komulainen J, Vikman E, et al. Autoimmune polyglandular disease type I: exclusion map using amplifiable multiallelic markers in a microtiter well format. Eur J Human Genet 1993; 1: 164 - 171.

    CAS  Google Scholar 

  178. Sander E, Prolla A, Marques R, Zelmanowitz T, Zampese M, Schwartsmann G. Reversal by interleukin2 of alopecia universalis, mucocutaneous candidiasis, and sexual impotence in a patient with malignant thymoma. J Natl Cancer Inst 1993; 85: 673.

    Article  PubMed  CAS  Google Scholar 

  179. Noh L, Hussein S, Sukumaran K, Rose I, Abdullah N. Chronic mucocutaneous candidiasis with deficient CD2 (E receptor) but normal CD3 mononuclear cells. J Clin Lab Immunol 1991; 35: 89 - 93.

    PubMed  CAS  Google Scholar 

  180. De Padova-Elder S, Detre C, Kantor G, et al. Candidiasis endocrinopathy syndrome. Arch Dermatol 1994; 130: 19.

    Article  Google Scholar 

  181. De Morales-Vasconcelos D, Orii NM, Romano CC, Iqueoka RY, Duarte AJ. Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis. Pathology 2001; 54: 81 - 83.

    Google Scholar 

  182. Nielsen E, Johansen H, Holt J, et al. Cl inhibitor and diagnosis of hereditary angiodema in newborns. Pediatr Res 1994; 35: 184 - 187.

    Article  PubMed  CAS  Google Scholar 

  183. Srinivasan J, Beck P. IgA nephropathy in heriditary angioedema. Postgrad Med J 1993; 69: 95.

    Article  PubMed  CAS  Google Scholar 

  184. Frank M, Gelfand J, Atkinson J. Heriditary angiodema: the clinical syndrome and its management. Ann Int Med 1984; 84: 580.

    Google Scholar 

  185. Verpy E, Biasotto M, Brai M, Misiano G, Meo T, Tose M. Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema. Am J Hum Genetics 1996; 59: 308 - 319.

    CAS  Google Scholar 

  186. Kume A, Denauer MC. Gene therapy for chronic granulomatous disease. J Lab Clin Med 2000; 135: 122 - 128.

    Article  PubMed  CAS  Google Scholar 

  187. Smith R, Curnutte J. Molecular basis of chronic granulomatous disease. Blood 1991; 77: 673 - 686.

    PubMed  CAS  Google Scholar 

  188. Lin SJ, Huang YE, Chen JY, et al. Molecular quality control machinery contributes to the leukocyte NADPH oxidase deficiency in chronic granulomatous disease. Biophysica Acta 2002; 1586: 276 - 286.

    Google Scholar 

  189. Patino PJ, Rae J, Noack D, et al. Molecular characterization of autosomal recessive chronic granulo-matous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 1999; 94: 2505 - 2614.

    PubMed  CAS  Google Scholar 

  190. Hopkins P, Bemiller L, Curnutte J. Chronic granulomatous disease: diagnosis and classification at the molecular level. Clin Lab Med 1992; 2: 277 - 304.

    Google Scholar 

  191. Veille J, Bigley R. Chronic granulomatous disease in pregnancy. Obstet Gynecol 1985; 66: 8S - 9S.

    PubMed  CAS  Google Scholar 

  192. Yamada H, Magoaka I, Takamori K, Ogawa H. Double filtration plasmapheresis enhances neutrophil chemotactic responses in hyperimmunoglobulin E syndrome. Artif Organs 1995; 19: 98 - 102.

    Article  CAS  Google Scholar 

  193. Bulengo-Ransby S, Headington J, Cantu-Gonzalez G, Rasmussen JE. Staphylococcal botryomycosis and hyperimmunoglobulin E (Jobs) syndrome in an infant. J Am Acad Dermatol 1993; 54: 109 - 111.

    Google Scholar 

  194. Pung YH, Vetro SW, Bellanti JA. Use of interferons in atopic (IgE-mediated) diseases. Ann. Allergy 1993; 71: 234 - 238.

    PubMed  CAS  Google Scholar 

  195. Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent-infection (Jobs) syndrome: a review of the NIH experience and the literature. Medicine 1983; 62: 195 - 208.

    CAS  Google Scholar 

  196. Leung DY, Geha RS. Critical and immunologic aspects of the hyperimmunoglobulin E syndrome. Hematol Oncol Clin North Am 1988; 2: 81 - 100.

    CAS  Google Scholar 

  197. Sandstrom B, Cederblad A, Lindblad B, Lonnerdal B. Acrodermatitis enteropathica, zinc metabolism, copper status, and immune function. Arch Pediatr Adolesc Med 1994; 148: 980 - 985.

    Article  PubMed  CAS  Google Scholar 

  198. Fitzpatrick J. Self assessment 1993: acrodermatitis enteropathica. J Cutan Pathol 1994; 21: 566 - 567.

    PubMed  CAS  Google Scholar 

  199. Jamison S. Effects of zinc deficiency in human reproduction. Acta Med Scand 1976; 593: 5 - 89.

    Google Scholar 

  200. Kynast G, Saling E. The relevance of zinc in pregnancy. J Perinat Med 1980; 8: 171 - 182.

    Article  PubMed  CAS  Google Scholar 

  201. Ruz M, Cavan KR, Bettger WJ, Thompson L, Berry M, Gilson RS. Development of a dietary model for the study of mild zinc deficiency in humans and evolution of some biochemical and functional indices of zinc status. Am J Clin Nutr 1991; 53: 1295 - 1303.

    PubMed  CAS  Google Scholar 

  202. Taylor A. Detection and monitoring of disorders of essential trace elements. Ann Clin Biochem 1996; 33: 486 - 510.

    PubMed  CAS  Google Scholar 

  203. Baker R, Manoharan A, DeLuca E, Begley CG. Pure red cell aplasia of pregnancy: a distinct clinical entity. Br J Haematol 1993; 85: 619 - 622.

    Article  PubMed  CAS  Google Scholar 

  204. Maung Z, Norden J, Middleton P, Jack FR, Chandler JE. Pure red cell aplasia: further evidence of T cell clonal disorder. Br J Haematol 1994; 87: 189 - 192.

    Article  PubMed  CAS  Google Scholar 

  205. Itoh Y, Aizawa S, Nehashi Y, et al. Pure red cell aplasia combined with pregnancy. Am J Hematol 1993; 43: 79.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Bennett, W.A. (2004). Immunologic Diseases of Pregnancy. In: Gronowski, A.M. (eds) Handbook of Clinical Laboratory Testing During Pregnancy. Current Clinical Pathology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-787-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-787-1_14

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9862-2

  • Online ISBN: 978-1-59259-787-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics